Study on prescription rules of health foods containing Dioscoreae Rhizoma and their immunity-enhancing functions based on “medicinal and edible homology” theory
ZHANG Xinxin, LI Yi, SHI Xiawei, YANG Junchao
Affiliations
doi: 10.7501/j.issn.0253-2670.2026.08.021
文章导航
摘要
收起
目的 利用数据挖掘、网络药理学及分子对接等技术分析含山药的保健食品的组方规律和保健功能，并分析潜在机制。方法 通过检索国家市场监督管理总局和药智网中含山药的保健食品，通过R语言进行频数统计，Apriori算法进行关联规则分析；TCMSP、HERB、HIT 2.0、ETCM 2.0、TCMID数据库检索山药活性成分并利用PubChem和SwissTargetPrediction数据库预测靶点，GeneGards、TTD、DrugBank、OMIM和PathCards数据库获取高频保健功能的潜在靶点，DAVID数据库实现功能富集分析；采用Auto Dock Vina对山药代表性成分和核心靶点进行分子对接验证，并利用GEO芯片数据进行核心靶点的受试者工作特征（receiver operator characteristic，ROC）曲线诊断。结果 纳入471种含山药的保健食品，剂型以胶囊剂为主，保健功能以有助于增强免疫力为主；涉及中药216味，以补虚药频次最高，药性以温性为主，药味以甘味为主，归经多归属肝经；枸杞子-山药、茯苓-山药为核心药对。网络药理学分析筛选获得山药相关活性成分294个、靶基因892个，有助于增强免疫力的潜在靶点共2 360个，PPI拓扑学分析挖掘5个枢纽靶点［信号转导和转录激活因子3（signal transducer and activator of transcription 3，STAT3）、表皮生长因子受体（epidermal growth factor receptor，EGFR）、蛋白激酶B1（protein kinase B1，AKT1）、白细胞介素6（interleukin 6，IL6）和肿瘤坏死因子（tumor necrosis factor，TNF）］，富集分析提示癌症通路、细胞凋亡、TNF信号通路和趋化因子信号通路等是山药及其配伍发挥增强免疫力的关键通路。分子对接提示枢纽靶点与山药的特征性成分尿囊素和薯蓣皂苷元对接良好。ROC曲线验证EGFR的良好诊断效能。结论 含山药的保健食品的组方规律以“山药-枸杞子”配伍支持度最高，山药和枸杞子、茯苓配伍可能以EGFR和AKT1等为核心靶点，在免疫力低下者中通过调控凋亡过程和炎症反应发挥增强免疫作用。
Objective To elucidate the formulation patterns and health functions of health products containing Shanyao (Dioscoreae Rhizoma) and explore the underlying mechanisms via data mining, network pharmacology, and molecular docking technologies. Methods Health products containing Dioscoreae Rhizoma were retrieved from the State Administration for Market Regulation and Yaozhi websites. Frequency analysis and Apriori algorithm-based association rule mining were implemented in R language. The TCMSP, HERB, HIT 2.0, ETCM 2.0, and TCMID databases were used to search for the active components of Dioscoreae Rhizoma, and the PubChem and SwissTargetPrediction databases were utilized to predict the targets. Then, potential targets associated with high-frequency health functions were obtained from GeneCards, TTD, DrugBank, OMIM, and PathCards databases. Functional enrichment analysis was subsequently performed using the DAVID database. Finally, molecular docking of representative Dioscoreae Rhizoma constituents with core targets was conducted using AutoDock Vina, followed by diagnostic evaluation via receiver operating characteristic (ROC) curve analysis based on GEO chip data. Results A total of 471 Dioscoreae Rhizoma-containing health products were included, dominated by capsules in formulation and targeting immune enhancement as the main health function. The formulas involved 216 types of Chinese medicinal materials, predominantly tonifying, warm in nature, sweet in taste, and attributed to the liver meridian. Gouqizi (Lycii Fructus)-Dioscoreae Rhizoma, Fuling (Poria)-Dioscoreae Rhizoma as the core medicinal ingredients. Network pharmacology analysis identified 294 active components and 892 related target genes from Dioscoreae Rhizoma, alongside 2 360 potential targets associated with the high-frequency health function of immune enhancement. Then, PPI topological analysis identified five core targets [signal transducer and activator of transcription 3 (STAT3), epidermal growth factor receptor (EGFR), protein kinase B1 (AKT1), interleukin 6 (IL6), and tumor necrosis factor (TNF)]. Enrichment analysis suggested that cancer pathway, cell apoptosis, TNF signaling pathway and chemokine signaling pathway were the key pathways for Dioscoreae Rhizoma and its compatibility to enhance immunity. Molecular docking revealed good binding affinity of core targets with characteristic components of Dioscoreae Rhizoma, notably, allantoin, dioscin, and diosgenin, with ROC analysis further confirming the diagnostic potency of EGFR. Conclusion This study identified “Dioscoreae Rhizoma-Lycii Fructus” as the core herb pair with the highest support degree in the formulation patterns of Dioscoreae Rhizoma-containing health products. The combination of Dioscoreae Rhizoma, Lycii Fructus, and Poria may take EGFR and AKT1 as core targets and exert an immune-enhancing effect by regulating the apoptosis process and inflammatory response in people with low immunity.
Key words
medicine food homology
/
Dioscoreae Rhizoma
/
health product
/
enhancing immunity
/
data mining
/
network pharmacology
/
Lycii Fructus
/
Poria
/
allantoin
/
diosgenin
ZHANG Xinxin, LI Yi, SHI Xiawei, YANG Junchao.
Study on prescription rules of health foods containing Dioscoreae Rhizoma and their immunity-enhancing functions based on “medicinal and edible homology” theory[J].
Chinese Traditional and Herbal Drugs,
2026
, 57
(8)
: 3085
-3098
.
DOI: 10.7501/j.issn.0253-2670.2026.08.021
基金
收起
浙江省卫生创新人才培养项目 (1S22411)
参考文献
收起
文献
收起
参考文献引证文献
排序方式：
孙欣缘, 郑雅萍, 孙康萌, 等. 我国食药物质名单梳理、修订与展望[J]. 中国中药杂志, 2025, 50(2):346-355. Cui Y F, Zhou Y Z, Li Y, et al. Chinese yam and its active components regulate the structure of gut microbiota and indole-like metabolites in anaerobic fermentation in vitro[J]. Nutrients, 2023, 15(24):5112. Ren X, Hu J H, Hong Y J, et al. Extraction, separation and efficacy of yam polysaccharide[J]. Int J Biol Macromol, 2024, 281:136167. 崔艺钒, 张璐佳, 丰宇, 等. 山药活性成分及营养功能研究进展[J]. 中国食品学报, 2022, 22(7):372-383. 《中国食物与营养发展纲要 (2025-2030年)》[J]. 营养学报, 2025, 47(2):105-107. 陈逸菲, 李佶. 基于数据挖掘和网络药理学探讨李佶教授治疗不孕症经间期证治用药规律[J]. 时珍国医国药, 2025, 36(24):4783-4791. 张真, 伊明洋, 李伟珂, 等. 从基础证探讨中药复方治疗慢性阻塞性肺疾病急性加重的用药规律及分子调控机制[J]. 中草药, 2025, 56(17):6278-6300. 黄新雨, 苗明三, 王灿. 山药的现代研究及其质量标志物预测分析[J]. 中华中医药学刊 (2025-07-04)[2026-04-10]. https://link.cnki.net/urlid/21.1546.R.20250704.1603.022. 宿婷婷, 赵旭, 汪坤, 等. 山药的质量控制现状及质量标志物预测分析[J]. 中国医院药学杂志, 2025, 45(12):1424-1430. Zhang G M, Sun S, Wang Y Y, et al. Unveiling Immune-related feature genes for Alzheimer's disease based on machine learning[J]. Front Immunol, 2024, 15:1333666. 郭盛, 王园园, 张芳, 等. 药食同源中药资源产业现状及其开发利用策略与研究实践[J]. 南京中医药大学学报, 2023, 39(9):801-808. 李香串, 乔丽芳, 任飒. 基于关联规则法研究黄芪在保健食品配方中的应用规律[J]. 山西医科大学学报, 2019, 50(1):40-49. 熊梦琪, 蔡静雯, 赵双庆, 等. 基于数据挖掘、网络药理学和分子对接的灵芝保健品组方规律及增强免疫力的保健功能研究[J]. 中草药, 2025, 56(13):4740-4751. 聂鏮倬, 李林玉, 杨雁, 等. 基于数据挖掘技术分析含余甘子的中成药及保健食品组方用药规律[J]. 亚太传统医药, 2025, 21(6):150-157. 骆宇欣, 徐佳漫, 郑君娜, 等. 基于数据挖掘和网络药理学的人参保健食品组方规律及主要保健功能研究[J]. 中草药, 2025, 56(16):5892-5905. 王婷. 保健食品中当归的应用规律[J]. 数理医药学杂志, 2024, 37(8):610-618. 鲍俊达, 王平, 陈瑞, 等. 基于数据挖掘分析含铁皮石斛保健食品配方规律[J]. 贵州中医药大学学报, 2022, 44(3):38-43. 赵小余, 杨云清, 王鑫, 等. 2017-2022年已备案国产保健食品信息统计分析与思考[J]. 中国食品卫生杂志, 2023, 35(6):884-891. Adomėnienė A, Venskutonis P R. Dioscorea spp. comprehensive review of antioxidant properties and their relation to phytochemicals and health benefits[J]. Molecules, 2022, 27(8):2530. 李慧敏, 贺凯, 郑慧, 等. 中医药健脾的保健作用机制及药食资源[J]. 中草药, 2020, 51(3):780-787. Domitien Payet L, Coléon A, Bedin A S, et al. Elderly individuals exhibit dysregulated monocyte responses to viral immune complexes compared to adults and children[J]. Sci Rep, 2025, 15(1):28186. Koren O, Konnikova L, Brodin P, et al. The maternal gut microbiome in pregnancy:Implications for the developing immune system[J]. Nat Rev Gastroenterol Hepatol, 2024, 21(1):35-45. Delaroque C, Rytter H, Bonazzi E, et al. Maternal emulsifier consumption alters the offspring early-life microbiota and goblet cell function leading to long-lasting diseases susceptibility[J]. Nat Commun, 2025, 16(1):6954. 张晓燕, 彭玉良. 基于"以甘制糖"探析甘味药在2型糖尿病中的运用规律[J]. 基层中医药, 2024, 3(5):88-95. 罗群, 金红宇, 杨建波, 等. 枸杞子功效主治、临床应用及现代药理作用研究进展[J]. 药物评价研究, 2024, 47(10):2427-2433. Zhang F Q, Li J C, Zhang R K, et al. Zeaxanthin augments CD8+ effector T cell function and immunotherapy efficacy[J]. Cell Rep Med, 2025, 6(9):102324. Lei J H, Gong D H, Duan L T, et al. A multidimensional perspective on Poria cocos, an ancient fungal traditional Chinese medicine[J]. J Ethnopharmacol, 2025, 348:119869. Pu Y W, Liu Z J, Tian H, et al. The immunomodulatory effect of Poria cocos polysaccharides is mediated by the Ca2+/PKC/p38/NF-κB signaling pathway in macrophages[J]. Int Immunopharmacol, 2019, 72:252-257. Zhang J Q, Wu C X, Gao L, et al. Astragaloside IV derived from Astragalus membranaceus:A research review on the pharmacological effects[J]. Adv Pharmacol, 2020, 87:89-112. Li Y, Zhang M, Zhang K Y, et al. Ginsenosides modulate immunity via TLR4/MyD88/NF-κB pathway and gut microbiota[J]. Phytomedicine, 2025, 142:156763. 钟亚东, 潘猛, 徐德昌, 等. 茯苓-山药复配米稀和猴头菇饼干对功能性消化不良大鼠的改善作用[J]. 食品工业科技, 2021, 42(22):355-362. Lu Y, Jin M H, Park S J, et al. Batatasin I, a naturally occurring phenanthrene derivative, isolated from tuberous roots of Dioscorea batatas suppresses eicosanoids generation and degranulation in bone marrow derived-mast cells[J]. Biol Pharm Bull, 2011, 34(7):1021-1025. 张贝贝, 曾梦楠, 贾菊芳, 等. 山药中熊果苷通过ERβ抑制LPS诱导NRK-52e细胞凋亡[J]. 中国药理学通报, 2022, 38(3):403-410. 苗常鑫, 冷锦红. 薯蓣皂苷的药理作用及机制研究进展[J]. 中华中医药学刊, 2024, 42(11):113-118. Zhang G T, Pan J S, Xu X Y, et al. Chinese yam polysaccharide enhances anti-PD-1 immunotherapy in colorectal cancer through alterations in the gut microbiota and metabolites[J]. Int J Biol Macromol, 2025, 310(Pt 2):143323. Shen M Y, Cai R X, Li Z D, et al. The molecular mechanism of yam polysaccharide protected H2O2-induced oxidative damage in IEC-6 cells[J]. Foods, 2023, 12(2):262. Liu X, Chen X X, Xie L M, et al. Sulfated Chinese yam polysaccharide enhances the immunomodulatory activity of RAW 264.7 cells via the TLR4-MAPK/NF-κB signaling pathway[J]. Food Funct, 2022, 13(3):1316-1326. 邢若, 王鹏, 李兴杰. 山药多糖对LPS诱导的心肌H9C2细胞炎症因子表达和细胞凋亡的影响及机制[J]. 中国免疫学杂志, 2021, 37(6):683-688. Yamaguchi H L, Yamaguchi Y, Peeva E. Role of innate immunity in allergic contact dermatitis:An update[J]. Int J Mol Sci, 2023, 24(16):12975. 殷萱, 郭修田, 崔凯宇, 等. 基于IL-6/STAT3信号通路探讨电针对溃疡性结肠炎小鼠Th17/Treg免疫平衡的影响[J]. 世界科学技术-中医药现代化, 2024, 26(11):2798-2805. Wang X Y, Hu R, Song Z W, et al. Sorafenib combined with STAT3 knockdown triggers ER stress-induced HCC apoptosis and cGAS-STING-mediated anti-tumor immunity[J]. Cancer Lett, 2022, 547:215880. Zou S L, Tong Q Y, Liu B W, et al. Targeting STAT3 in cancer immunotherapy[J]. Mol Cancer, 2020, 19(1):145. Sabbah D A, Hajjo R, Sweidan K. Review on epidermal growth factor receptor (EGFR) structure, signaling pathways, interactions, and recent updates of EGFR inhibitors[J]. Curr Top Med Chem, 2020, 20(10):815-834. Torasawa M, Yoshida T, Shiraishi K, et al. Implications of EGFR expression on EGFR signaling dependency and adaptive immunity against EGFR-mutated lung adenocarcinoma[J]. Lung Cancer, 2025, 202:108494. Wu S Y, Zhang Q, Zhang F, et al. HER2 recruits AKT1 to disrupt STING signalling and suppress antiviral defence and antitumour immunity[J]. Nat Cell Biol, 2019, 21(8):1027-1040. Nie Y J, Hu Y D, Yu K K, et al. Akt1 regulates pulmonary fibrosis via modulating IL-13 expression in macrophages[J]. Innate Immun, 2019, 25(7):451-461. Tornesello M L. TP53 mutations in cancer:Molecular features and therapeutic opportunities (Review)[J]. Int J Mol Med, 2025, doi:10.3892/ijmm.2024.5448. Hu M M, He W R, Gao P, et al. Virus-induced accumulation of intracellular bile acids activates the TGR5-β-arrestin-SRC axis to enable innate antiviral immunity[J]. Cell Res, 2019, 29(3):193-205. 刘佳宁, 李遇伯, 王玉丽, 等. 基于配伍相互作用的中药合理用药研究进展及监管思考[J]. 中草药, 2023, 54(2):375-385. 王小兰, 李方, 孙墨, 等. 山药中尿囊素对环磷酰胺诱导卵巢功能早衰的保护作用[J]. 天然产物研究与开发, 2023, 35(12):2137-2144. Dong M X, Meng Z F, Kuerban K, et al. Diosgenin promotes antitumor immunity and PD-1 antibody efficacy against melanoma by regulating intestinal microbiota[J]. Cell Death Dis, 2018, 9(10):1039. Xu Y H, Lan P X, Wang T. The role of immune cells in the pathogenesis of idiopathic pulmonary fibrosis[J]. Medicina, 2023, 59(11):1984. Porter R J, Kalla R, Ho G T. Ulcerative colitis:Recent advances in the understanding of disease pathogenesis[J]. F1000Res, 2020, 9:F1000Faculty Re294. Zoccali C, Mallamaci F. Innate immunity system in patients with cardiovascular and kidney disease[J]. Circ Res, 2023, 132(8):915-932.
PDF下载
全屏
31
11
关闭全屏
北京市海淀区学院南路86号
010-62199257（仅加盟咨询）
qkjq@cast.org.cn
